Bundamedik Future Growth
Future criteria checks 1/6
Bundamedik is forecast to grow revenue at 10.5% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 18.9% |
| Revenue growth rate | 10.5% |
| Future return on equity | 3.8% |
| Analyst coverage | Low |
| Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,932,000 | N/A | N/A | 189,000 | 1 |
| 12/31/2025 | 1,736,000 | N/A | N/A | 170,000 | 1 |
| 12/31/2024 | 1,553,000 | N/A | N/A | 299,000 | 1 |
| 9/30/2024 | 1,546,345 | 13,050 | -223,370 | 61,330 | N/A |
| 6/30/2024 | 1,550,932 | 14,165 | -218,820 | 52,573 | N/A |
| 3/31/2024 | 1,516,514 | 8,378 | -164,487 | 28,889 | N/A |
| 12/31/2023 | 1,488,197 | 7,461 | -157,915 | 51,439 | N/A |
| 9/30/2023 | 1,528,827 | 15,708 | -25,880 | 66,366 | N/A |
| 6/30/2023 | 1,565,526 | 34,028 | 24,224 | 96,722 | N/A |
| 3/31/2023 | 1,655,224 | 64,463 | -46,987 | 134,687 | N/A |
| 12/31/2022 | 1,658,688 | 83,228 | -170,646 | 131,084 | N/A |
| 9/30/2022 | 1,796,504 | 96,161 | -227,176 | 306,568 | N/A |
| 6/30/2022 | 1,803,530 | 133,169 | -254,125 | 298,580 | N/A |
| 3/31/2022 | 1,829,486 | 178,965 | -113,811 | 352,809 | N/A |
| 12/31/2021 | 1,890,800 | 214,489 | 51,263 | 349,438 | N/A |
| 9/30/2021 | 1,657,759 | 214,536 | 100,156 | 199,995 | N/A |
| 6/30/2021 | 1,585,714 | 207,760 | 138,256 | 201,985 | N/A |
| 3/31/2021 | 1,366,053 | 145,128 | 123,810 | 163,858 | N/A |
| 12/31/2020 | 1,148,144 | 88,791 | 140,752 | 190,359 | N/A |
| 12/31/2019 | 964,893 | 19,895 | 17,214 | 89,715 | N/A |
| 12/31/2018 | 852,233 | 5,128 | -41,146 | 115,396 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BMHS's forecast earnings growth is above the savings rate (6.8%).
Earnings vs Market: Insufficient data to determine if BMHS's earnings are forecast to grow faster than the ID market
High Growth Earnings: Insufficient data to determine if BMHS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BMHS's revenue (10.5% per year) is forecast to grow faster than the ID market (9.7% per year).
High Growth Revenue: BMHS's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BMHS's Return on Equity is forecast to be low in 3 years time (3.8%).